Directori de persones
Juan Antonio Schoenenberger Arnaiz

Juan Antonio Schoenenberger Arnaiz

Grau: Doctor/a

973 705 220
jas.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/B-5701-2009

Grups

Publicacions

  • Rivera-Izquierdo, M; Morales-Portillo, A; de Alba, IGF; Fernandez-Martinez, NF; Schoenenberger-Arnaiz, JA; Barranco-Quintana, JL; Valero-Ubierna, C

    Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024

    EXPERT REVIEW OF VACCINES 23 887-910. .

    [doi:10.1080/14760584.2024.2401839]

  • Jover-Saenz, A; Santos Rodríguez C; Ramos Gil MÁ; Palomera Fernández M; Invencio da Costa LF; Torres-Puig-gros, J; Castellana Perelló D; Montiu González E; Schoenenberger-Arnaiz, JA; Bordalba Gómez JR; Galindo Ortego X; Ramirez-Hidalgo, M

    Impact of an Antimicrobial Stewardship Strategy on Surgical Hospital Discharge: Improving Antibiotic Prescription in the Transition of Care.

    Antibiotics-Basel 12 -. .

    [doi:10.3390/antibiotics12050834]

  • Taberner Bonastre P; Torres Vicente G; Cano-Marron M; Sese Abizanda E; Volta Pardo TD; Schoenenberger-Arnaiz JA

    A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib.

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 28 353-355. .

    [doi:10.1136/ejhpharm-2020-002437]

  • Romero I; Rubio MJ; Medina M; Matias-Guiu X; Santacana M; Schoenenberger JA; Guerra EM; Cortés A; Minig L; Coronado P; Cueva JF; Gómez L; Malfettone A; Sampayo M; Llombart-Cussac A; Poveda A

    An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.

    GYNECOLOGIC ONCOLOGY 159 721-731. .

    [doi:10.1016/j.ygyno.2020.09.013]

  • Schoenenberger-Arnaiz, JA; Ahmad-Diaz, F; Miralbes-Torner, M; Aragones-Eroles, A; Cano-Marron, M; Palomar-Martinez, M

    Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 27 30-35. .

    [doi:10.1136/ejhpharm-2018-001713]

  • Porcel, JM; Ferreiro, L; Rumi, L; Espino-Paisan, E; Civit, C; Pardina, M; Schoenenberger-Arnaiz, JA; Valdes, L; Bielsa, S

    Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial

    Pleura and Peritoneum 5 20190027-20190027. .

    [doi:10.1515/pp-2019-0027]

  • Romero, I; Rubio, MJ; Medina, M; Serrano, R; Guerra, EM; Salgado, AC; Perez, B; Minig, L; Casado, A; Coronado, P; Cueva, JF; Vilar, A; Torne, A; Ordi, J; Cros, S; Salinas, G; Santacana, M; Schoenenberger-Arnaiz, JA; Llombart-Cussac, A; Poveda, A

    Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study).

    Journal of Clinical Oncology 36 5598-5598. .

    [doi:10.1200/JCO.2018.36.15_suppl.5598]

  • Teixido, C; Diez, O; Marsal, JR; Giner-Soriano, M; Pera, H; Martinez, M; Galindo-Ortego, G; Schoenenberger, JA; Real, J; Cruz, I; Morros, R

    Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum

    PEDIATRIC DERMATOLOGY 35 336-342. .

    [doi:10.1111/pde.13438]

  • Rivera K; Marzo C; Sans N; Ferrero A; Aldomà A; Schoenenberger JA; Galván L; Worner F

    Consensus is Possible: Initiation and Exchange of Oral Anticoagulants in Non-valvular Atrial Fibrillation, According to a Territorial Protocol in a Period of Time.

    European Cardiology 12 104-104. .

    [doi:10.15420/ecr.2017:23:13]

  • Vallez-Valero, L.; Rius-Perera, J.; Gilabert Sotoca, M.; Mangues-Bafalluy, I; Schoenenberger, J. A.; Salud-Salvia, M. A.

    USE OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT-PROSTATE CANCER IN ROUTINE CLINICAL PRACTICE

    VALUE IN HEALTH 20 417-417. .

    [doi:10.1016/j.jval.2017.08.114]

  • Torres-Bondia, FI; Parada-Saavedra, FJ; Fernandez-Armenteros, JM; Schoenenberger-Arnaiz, JA

    Non-uremic calciphylaxis due to acenocoumarol

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 41 569-570. .

    [doi:10.7399/fh.2017.41.4.10775]

  • Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs E; Moiola, C; Schoenenberger, JA; Encinas, M; Gari, E; Matias-Guiu, X; Dolcet, X

    Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    JOURNAL OF PATHOLOGY 242 152-164. .

    [doi:10.1002/path.4896]

Projectes

  • DURADA OPTIMA DEL TRACTAMENT ANTIBIOTIC EN PACIENTS AMB VESSAMENT PLEURAL PARAPNEUMONIC COMPLICAT O EMPIEMA: ASSAIG CLINIC RANDOMITZAT
  • MULTINUTRIENT MAIZE: MULTIVITAMIN AND MULTIMINERAL FORTIFIED MAIZE FOR FOOD SECURITY
  • APLICACIO DE LA DETERMINACIO DE NIVELLS PLASMATICS D'ANTIRETROVIRALS A LA DETECCIO DE PROBLEMES RELACIONATS AMB LA MEDICACIO (PRM) EN PACIENTS EN TRACTAMENT PER A LA INFECCIO PER HIV